IRMA MENDOZA-MONTOYA: Open Payments
NPI 1609292614 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 15 payments from 13 companies in 2025. Trend: 2023 $21 · 2024 $0 · 2025 $433
Food & beverage: $333Education: $100
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $100 |
| Daiichi Sankyo Inc. | 2 | $49 |
| TerSera Therapeutics LLC | 2 | $34 |
| Janssen Biotech, Inc. | 1 | $31 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Amgen Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Genmab U.S., Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Exelixis Inc. | 1 | $24 |
Products named: Enhertu, Zoladex, TALVEY, KEYTRUDA QLEX, EVENITY, OJJAARA, Epkinly, LIBTAYO.
Industry payments across OR — which companies pay providers there.
